Scholarlink

Background <p>Breast cancer is the most commonly diagnosed cancer globally. The potential role of oncogenic viruses, particularly Human Betaretrovirus (HBRV, formerly MMTV-LV/HMTV), in the pathogenesis of breast cancer has been a subject of research for decades. However, studies investigating this association have produced conflicting results. This systematic review and meta-analysis aim to assess the prevalence of HBRV in breast cancer cases and evaluate its potential association with breast cancer.</p> Methods <p>A systematic literature search was conducted in MEDLINE, Web of Science, Scopus, and EMBASE following PRISMA guidelines. Studies assessing HBRV prevalence in breast cancer patients and case-control studies investigating its association with breast cancer risk were included. The Newcastle-Ottawa Scale (NOS) was used to evaluate study quality, and meta-analysis was performed using RevMan 5.1. Heterogeneity was assessed using the I² statistic, and subgroup analyses were conducted based on detection methods, sample types, and geographic regions.</p> Results <p>The literature search identified a total of 45 studies that were deemed suitable for inclusion in the systematic review. 26 studies were used in the subsequent meta-analysis. The initial meta-analysis revealed a significant association between HBRV and breast cancer (OR = 4.92, 95% CI: 4.00–6.04, <i>p</i> &lt; 0.00001) but exhibited high heterogeneity (I² = 82%). After excluding an outlier, heterogeneity was significantly reduced (I² = 22%), with a revised OR of 11.95 (95% CI: 8.78–16.25, <i>p</i> &lt; 0.00001 ). Subgroup analysis demonstrated variation in detection methods, with Nested PCR (OR = 19.15) and Frozen tissue samples (OR = 18.00) showing the strongest associations. Geographic analysis indicated the highest odds in North America (OR = 24.75), followed by Europe (OR = 15.02).</p> Conclusion <p>This meta-analysis suggests strong epidemiological evidence supporting an association between HBRV infection and human breast cancer, and is consistent with a possible etiological role. However, variability in study methodologies and geographic differences warrant further investigation through standardized, large-scale studies to confirm these findings and explore potential mechanisms of viral oncogenesis in breast cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Human betaretrovirus (HBRV), homologous to mouse mammary tumor virus (MMTV), and human breast cancer: a significant epidemiological association

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月9日

查看全文
  • Fateme Saeedi-Moghaddam,
  • Nazila Saffarian,
  • Sayed-Hamidreza Mozhgani

摘要

Background

Breast cancer is the most commonly diagnosed cancer globally. The potential role of oncogenic viruses, particularly Human Betaretrovirus (HBRV, formerly MMTV-LV/HMTV), in the pathogenesis of breast cancer has been a subject of research for decades. However, studies investigating this association have produced conflicting results. This systematic review and meta-analysis aim to assess the prevalence of HBRV in breast cancer cases and evaluate its potential association with breast cancer.

Methods

A systematic literature search was conducted in MEDLINE, Web of Science, Scopus, and EMBASE following PRISMA guidelines. Studies assessing HBRV prevalence in breast cancer patients and case-control studies investigating its association with breast cancer risk were included. The Newcastle-Ottawa Scale (NOS) was used to evaluate study quality, and meta-analysis was performed using RevMan 5.1. Heterogeneity was assessed using the I² statistic, and subgroup analyses were conducted based on detection methods, sample types, and geographic regions.

Results

The literature search identified a total of 45 studies that were deemed suitable for inclusion in the systematic review. 26 studies were used in the subsequent meta-analysis. The initial meta-analysis revealed a significant association between HBRV and breast cancer (OR = 4.92, 95% CI: 4.00–6.04, p < 0.00001) but exhibited high heterogeneity (I² = 82%). After excluding an outlier, heterogeneity was significantly reduced (I² = 22%), with a revised OR of 11.95 (95% CI: 8.78–16.25, p < 0.00001 ). Subgroup analysis demonstrated variation in detection methods, with Nested PCR (OR = 19.15) and Frozen tissue samples (OR = 18.00) showing the strongest associations. Geographic analysis indicated the highest odds in North America (OR = 24.75), followed by Europe (OR = 15.02).

Conclusion

This meta-analysis suggests strong epidemiological evidence supporting an association between HBRV infection and human breast cancer, and is consistent with a possible etiological role. However, variability in study methodologies and geographic differences warrant further investigation through standardized, large-scale studies to confirm these findings and explore potential mechanisms of viral oncogenesis in breast cancer.